🔍
Compositions and Methods of Increasing RNA Translation
Case ID:
C18083
Report of Invention:
10/12/2023
Web Published:
1/16/2024
Value Proposition
mRNA use for therapeutic purposes has proven useful in treating a wide array of diseases.
Major challenges of mRNA therapies include immunogenicity, poor expression, and low stability.
This therapy contains modifications improving mRNA stability, efficiency, and immunogenicity.
This technology allows for the translation of almost any exogenously delivered mRNA therapy.
Unmet Need
mRNA therapeutics are becoming increasingly utilized in the medical space due to their specificity and ability to treat a wide array of diseases. While there are many benefits to mRNA-based therapeutics, there is a growing need for therapeutics designed to limit undesired immunogenicity, increase transfection efficiency, and increase stability of mRNA therapeutic for greater therapeutic efficacy.
Technology Description
Reported here is SPARX (Sequence Promoting the Amplification of RNA Expression) an mRNA aptamer-based therapeutic design approach aiming to tackle the typical limitations of mRNA-based therapeutics. Through modifications on the aptamer, SPARX is capable of reducing immunogenicity, increasing mRNA stability, and promoting increased expression of exogenous mRNA through optimal ribosomal binding. Altogether, SPARX has the potential to increase efficiency, stability, and efficacy of mRNA-based therapeutics.
Stage of Development
In vitro proof of concept
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
RNA Aptamer for Enhancing the Expression of Synthetic mRNA Vaccines and Therapies
PRO: Provisional
United States
63/740,390
12/31/2024
Pending
Direct Link:
https://jhu.technologypublisher.com/technology/53078
Inventors:
Category(s):
Clinical and Disease Specializations, Technology Classifications > Therapeutic Modalities > Cell Therapies, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Vaccines,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Vera Sampels
vsampel2@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum